NCT03635346 (DEMDOU) is a clinical trial in Opiate Dependence, sponsored by University Hospital, Brest.

Who is sponsoring NCT03635346?

NCT03635346 is sponsored by University Hospital, Brest.

What condition does NCT03635346 study?

NCT03635346 studies Opiate Dependence, Chronic Pain.

Is NCT03635346 still recruiting?

NCT03635346 is currently completed. Last updated 17 August 2018.

Last reviewed 2018-08-17 · How we verify

NCT03635346: DEMDOU

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Medicinal Dependence and Chronic Pain: Addictive Evaluation in CETD

Completed Last updated 17 August 2018

What this trial tests

trial in Opiate Dependence in 128 participants. Completed in 10 March 2018.

Timeline

3 June 2016

Primary endpoint
3 September 2016

10 March 2018

Quick facts

Lead sponsor	University Hospital, Brest
Status	Completed
Study type	OBSERVATIONAL
Enrollment	128
Start date	3 June 2016
Primary completion	3 September 2016
Estimated completion	10 March 2018
Sites	1 location across France

Conditions studied

Opiate Dependence — all drugs for Opiate Dependence →
Chronic Pain — all drugs for Chronic Pain →

Sponsor

University Hospital, Brest

Who can join

Adults 18 to 85, any sex, with Opiate Dependence or Chronic Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

prescription opioid misuse in chronic pain is a growing public health concern. few studies got interested in prevalence of misuse and of opiate use disorder in a population of patients with a non cancer chronic pain. the investigators analyzed during 3 months opiate misuse and opiate ude disorder in a population of patients consulting a center specialized in pain management.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University Hospital, Brest trials

Trials by the same sponsor.

NCT07526688 — Aerobic Physical Activity and Orofacial Myofascial Pain · NA · not yet recruiting
NCT07487155 — Unified Junction of Care, Integrated Treatments and Team Coordination for ADHD in Prison Settings With Substance Use Dis · NA · not yet recruiting
NCT07417605 — Diagnostic Performance Of 4D Dynamic LAFOV FDG-PET Acquisition for Differentiation of Residual Disease and Post-radiatio · not yet recruiting
NCT07302074 — Understanding of Rare Inflammatory Arthritis in Comparison to Classical Inflammatory Arthritis : Tissular Observations a · NA · recruiting
NCT06441773 — Impact of Respiratory Rehabilitation on Quality of Life in Patients With Metastatic Non-small Cell Lung Cancer Treated W · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03635346 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Brest
Last refreshed: 17 August 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03635346.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing